diomed developments limited

Live MatureLargeLow

diomed developments limited Company Information

Share DIOMED DEVELOPMENTS LIMITED

Company Number

00745839

Shareholders

diomed group holdings limited

Group Structure

View All

Industry

Manufacture of basic pharmaceutical products

 

Registered Address

haslers, old station road, loughton, essex, IG10 4PL

diomed developments limited Estimated Valuation

£192.9m

Pomanda estimates the enterprise value of DIOMED DEVELOPMENTS LIMITED at £192.9m based on a Turnover of £62.2m and 3.1x industry multiple (adjusted for size and gross margin).

diomed developments limited Estimated Valuation

£54.4m

Pomanda estimates the enterprise value of DIOMED DEVELOPMENTS LIMITED at £54.4m based on an EBITDA of £4.2m and a 13.04x industry multiple (adjusted for size and gross margin).

diomed developments limited Estimated Valuation

£124.8m

Pomanda estimates the enterprise value of DIOMED DEVELOPMENTS LIMITED at £124.8m based on Net Assets of £76.6m and 1.63x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Diomed Developments Limited Overview

Diomed Developments Limited is a live company located in loughton, IG10 4PL with a Companies House number of 00745839. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in January 1963, it's largest shareholder is diomed group holdings limited with a 100% stake. Diomed Developments Limited is a mature, large sized company, Pomanda has estimated its turnover at £62.2m with low growth in recent years.

View Sample
View Sample
View Sample

Diomed Developments Limited Health Check

Pomanda's financial health check has awarded Diomed Developments Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 5 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4.5out of 5
positive_score

6 Strong

positive_score

1 Regular

positive_score

5 Weak

size

Size

annual sales of £62.2m, make it larger than the average company (£36.9m)

£62.2m - Diomed Developments Limited

£36.9m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (5.1%)

3% - Diomed Developments Limited

5.1% - Industry AVG

production

Production

with a gross margin of 56.5%, this company has a lower cost of product (36.5%)

56.5% - Diomed Developments Limited

36.5% - Industry AVG

profitability

Profitability

an operating margin of 3.6% make it less profitable than the average company (7.4%)

3.6% - Diomed Developments Limited

7.4% - Industry AVG

employees

Employees

with 299 employees, this is above the industry average (118)

299 - Diomed Developments Limited

118 - Industry AVG

paystructure

Pay Structure

on an average salary of £60.7k, the company has an equivalent pay structure (£63.3k)

£60.7k - Diomed Developments Limited

£63.3k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £208k, this is less efficient (£431.8k)

£208k - Diomed Developments Limited

£431.8k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 81 days, this is later than average (61 days)

81 days - Diomed Developments Limited

61 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 57 days, this is slower than average (32 days)

57 days - Diomed Developments Limited

32 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 248 days, this is more than average (110 days)

248 days - Diomed Developments Limited

110 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 162 weeks, this is more cash available to meet short term requirements (9 weeks)

162 weeks - Diomed Developments Limited

9 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 9.4%, this is a lower level of debt than the average (41%)

9.4% - Diomed Developments Limited

41% - Industry AVG

DIOMED DEVELOPMENTS LIMITED financials

EXPORTms excel logo

Diomed Developments Limited's latest turnover from May 2024 is £62.2 million and the company has net assets of £76.6 million. According to their latest financial statements, Diomed Developments Limited has 299 employees and maintains cash reserves of £24.5 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017May 2016May 2015May 2014May 2013May 2012May 2011May 2010
Turnover62,183,24058,120,76462,567,83057,379,61155,190,30158,037,82758,743,97960,205,01761,785,66861,897,57659,960,75456,887,86050,680,46347,308,80644,606,431
Other Income Or Grants
Cost Of Sales27,032,93223,779,30926,132,41221,665,92520,981,95522,455,30522,084,51822,958,04424,201,87723,430,56322,295,66221,482,03518,791,28216,902,32416,995,704
Gross Profit35,150,30834,341,45536,435,41835,713,68634,208,34635,582,52236,659,46137,246,97337,583,79138,467,01337,665,09235,405,82531,889,18130,406,48227,610,727
Admin Expenses32,942,46933,001,53732,339,62028,357,32929,486,91329,479,73129,051,96628,089,64828,053,55629,946,21829,004,76029,247,55826,494,43924,607,51223,384,577
Operating Profit2,207,8391,339,9184,095,7987,356,3574,721,4336,102,7917,607,4959,157,3259,530,2358,520,7958,660,3326,158,2675,394,7425,798,9704,226,150
Interest Payable6461,93675,5251472074202781,222187791,3591,9002,673
Interest Receivable411,0541,09766715,501155,947138,22965,82738,06575,47779,18237,78938,21231,48626,4833,718
Pre-Tax Profit2,618,2471,339,0794,096,4587,366,3334,877,2336,240,8137,672,9029,195,1129,604,4908,599,7908,698,1216,196,4005,424,8695,823,5534,227,195
Tax-22,245510,24473,114-103,982508,510-46,171-329,865-900,167-932,543-832,939-1,081,402-813,532-742,616-1,144,655-718,705
Profit After Tax2,596,0021,849,3234,169,5727,262,3515,385,7436,194,6427,343,0378,294,9458,671,9477,766,8517,616,7195,382,8684,682,2534,678,8983,508,490
Dividends Paid2,900,0001,500,0003,500,0003,500,0003,500,0003,500,0002,500,0002,500,0002,500,0002,000,000
Retained Profit2,575,5041,832,9731,223,6097,250,3683,869,3192,683,0633,831,2274,804,9715,171,9475,266,8515,116,7195,382,8682,182,2534,678,9221,508,490
Employee Costs18,149,32918,271,60516,457,59715,776,16814,021,77614,251,87614,495,86812,814,38711,437,69210,560,8509,793,5479,517,4268,397,4877,679,9697,203,141
Number Of Employees299302290261256247238226218198189168162146144
EBITDA*4,174,1682,951,6405,437,8978,564,5205,885,7557,099,0678,603,7739,985,78510,248,8679,177,8849,273,5876,672,8955,933,6486,376,9384,813,365

* Earnings Before Interest, Tax, Depreciation and Amortisation

May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017May 2016May 2015May 2014May 2013May 2012May 2011May 2010
Tangible Assets26,239,87825,682,51020,140,16017,053,98317,090,35915,079,34714,584,72913,859,46011,868,78511,650,46110,564,1289,511,8266,444,0166,298,9576,403,499
Intangible Assets80,00080,00080,00080,00080,00080,00062,21444,43066,64688,862111,078133,294155,510177,726199,942
Investments & Other52,68232,18415,83461,79749,81433,39021,81110,001
Debtors (Due After 1 year)15,751
Total Fixed Assets26,372,56025,794,69420,235,99417,195,78017,220,17315,208,48814,668,75413,913,89111,935,43111,739,32310,675,2069,645,1206,599,5266,476,6836,603,441
Stock & work in progress18,401,48714,512,99811,900,23312,207,85010,395,3529,625,2209,130,0549,593,8006,343,0227,552,0928,988,1868,326,1325,408,4774,863,4263,916,312
Trade Debtors13,871,96111,725,48813,982,86314,073,12414,353,27211,061,07411,250,53311,471,82512,125,07011,227,93911,217,72511,961,32411,180,84210,029,5158,970,294
Group Debtors1,3822,522252
Misc Debtors1,357,3472,340,1551,842,5531,951,5441,983,1921,236,0751,290,2421,325,6022,322,795573,186473,1391,571,6431,672,9941,288,1841,192,125
Cash24,508,69226,976,97035,254,08037,090,78431,048,59830,961,80229,888,14622,007,41521,457,69016,052,07210,568,6625,031,9944,683,2064,004,9841,112,403
misc current assets
total current assets58,140,86955,555,61162,982,25165,323,55457,780,41452,884,17151,558,97544,398,64242,248,57735,405,28931,247,71226,891,09322,945,51920,186,10915,191,134
total assets84,513,42981,350,30583,218,24582,519,33475,000,58768,092,65966,227,72958,312,53354,184,00847,144,61241,922,91836,536,21329,545,04526,662,79221,794,575
Bank overdraft4,320240,6381,950,5691,618,639428,02220,808893,266
Bank loan
Trade Creditors 4,293,3594,226,0608,113,9127,363,7456,034,8733,885,9988,233,8144,107,6202,573,7763,529,948604,543864,0981,018,118500,638447,614
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities3,553,0633,095,9832,431,5002,802,6674,030,7482,661,0322,459,8722,792,2673,302,3802,437,4514,613,7461,996,4202,381,3432,567,1081,558,355
total current liabilities7,846,4227,322,04310,545,41210,166,41210,065,6216,551,35010,934,3246,899,8877,826,7255,967,3995,218,2894,479,1573,827,4833,088,5542,899,235
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities409,626
provisions84,15161,906572,150645,264501,6421,010,152968,469942,557692,140684,042589,476649,000102,000140,929140,929
total long term liabilities84,15161,906572,150645,264501,6421,010,152968,469942,557692,140684,042589,4761,058,626102,000140,929140,929
total liabilities7,930,5737,383,94911,117,56210,811,67610,567,2637,561,50211,902,7937,842,4448,518,8656,651,4415,807,7655,537,7833,929,4833,229,4833,040,164
net assets76,582,85673,966,35672,100,68371,707,65864,433,32460,531,15754,324,93650,470,08945,665,11840,493,17136,115,15330,998,43025,615,56223,433,30918,754,387
total shareholders funds76,582,85673,966,35672,100,68371,707,65864,433,32460,531,15754,324,93650,470,08945,665,11840,493,17136,115,15330,998,43025,615,56223,433,30918,754,387
May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017May 2016May 2015May 2014May 2013May 2012May 2011May 2010
Operating Activities
Operating Profit2,207,8391,339,9184,095,7987,356,3574,721,4336,102,7917,607,4959,157,3259,530,2358,520,7958,660,3326,158,2675,394,7425,798,9704,226,150
Depreciation1,966,3291,611,7221,342,0991,208,1631,164,322974,062974,062806,244696,416634,873591,039492,412516,690555,752564,999
Amortisation22,21422,21622,21622,21622,21622,21622,21622,21622,21622,216
Tax-22,245510,24473,114-103,982508,510-46,171-329,865-900,167-932,543-832,939-1,081,402-813,532-742,616-1,144,655-718,705
Stock3,888,4892,612,765-307,6171,812,498770,132495,166-463,7463,250,778-1,209,070-1,436,094662,0542,917,655545,051947,1143,916,312
Debtors1,165,047-1,762,295-196,982-311,5444,023,564-227,875-256,652-1,650,4382,646,740110,261-1,842,103679,1311,536,1371,155,28010,162,419
Creditors67,299-3,887,852750,1671,328,8722,148,875-4,347,8164,126,1941,533,844-956,1722,925,405-259,555-154,020517,48053,024447,614
Accruals and Deferred Income457,080664,483-371,167-1,228,0811,369,716201,160-332,395-510,113864,929-2,176,2952,617,326-384,923-185,7651,008,7531,558,355
Deferred Taxes & Provisions22,245-510,244-73,114143,622-508,51041,68325,912250,4178,09894,566-59,524547,000-38,929140,929
Cash flow from operations-354,989-1,122,1996,321,4967,203,9974,610,6502,680,63212,814,0178,759,4267,795,50910,514,45411,670,4812,270,6343,402,6304,191,666-7,837,173
Investing Activities
capital expenditure-1,643,470-1,738,938-2,799,541-838,763-1,709,960-1,624,654-3,763,559-651,007-451,189-690,845
Change in Investments20,49816,350-45,96311,98316,42411,57911,81010,001
cash flow from investments-20,498-16,35045,963-11,983-16,424-1,655,049-1,750,748-2,809,542-838,763-1,709,960-1,624,654-3,763,559-651,007-451,189-690,845
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities-409,626409,626
share issue40,99632,700-830,58423,96632,8483,523,15823,620-888,833417,245,897
interest410,408-8396609,976155,800138,02265,40737,78774,25578,99537,78938,13330,12724,5831,045
cash flow from financing451,40431,861-829,92433,942188,6483,661,18089,02737,78774,255-809,838-371,833447,75930,12724,58317,246,942
cash and cash equivalents
cash-2,468,278-8,277,110-1,836,7046,042,18686,7961,073,6567,880,731549,7255,405,6185,483,4105,536,668348,788678,2222,892,5811,112,403
overdraft-4,320-236,318240,638-1,950,5691,950,569-1,618,6391,190,617407,214-872,458893,266
change in cash-2,468,278-8,277,110-1,836,7046,042,18691,1161,309,9747,640,0932,500,2943,455,0495,483,4107,155,307-841,829271,0083,765,039219,137

diomed developments limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for diomed developments limited. Get real-time insights into diomed developments limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Diomed Developments Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for diomed developments limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in IG10 area or any other competitors across 12 key performance metrics.

diomed developments limited Ownership

DIOMED DEVELOPMENTS LIMITED group structure

Diomed Developments Limited has 6 subsidiary companies.

DIOMED DEVELOPMENTS LIMITED Shareholders

diomed group holdings limited 100%

diomed developments limited directors

Diomed Developments Limited currently has 3 directors. The longest serving directors include Mr Michael Yarrow (Nov 1991) and Ms Heather Yarrow (May 2006).

officercountryagestartendrole
Mr Michael YarrowUnited Kingdom77 years Nov 1991- Director
Ms Heather YarrowUnited Kingdom75 years May 2006- Director
Ms Nicola YarrowUnited Kingdom37 years Jun 2016- Director

P&L

May 2024

turnover

62.2m

+7%

operating profit

2.2m

+65%

gross margin

56.6%

-4.33%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

May 2024

net assets

76.6m

+0.04%

total assets

84.5m

+0.04%

cash

24.5m

-0.09%

net assets

Total assets minus all liabilities

diomed developments limited company details

company number

00745839

Type

Private limited with Share Capital

industry

21100 - Manufacture of basic pharmaceutical products

incorporation date

January 1963

age

62

incorporated

UK

ultimate parent company

accounts

Group

last accounts submitted

May 2024

previous names

dermal laboratories limited (December 1981)

accountant

-

auditor

HASLERS

address

haslers, old station road, loughton, essex, IG10 4PL

Bank

TRUSTEE SAVINGS BANK

Legal Advisor

-

diomed developments limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 3 charges/mortgages relating to diomed developments limited. Currently there are 0 open charges and 3 have been satisfied in the past.

diomed developments limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for DIOMED DEVELOPMENTS LIMITED. This can take several minutes, an email will notify you when this has completed.

diomed developments limited Companies House Filings - See Documents

datedescriptionview/download